Go from trial and error to test and treat.

Pharmacogenomics, also known as PGx, is the study of how a person’s genes affect how he or she responds to medications. The goal of PGx is to help doctors personalize a patient’s treatment – selecting the drugs and doses best suited for each individual patient. IDgenetix is an advanced precision medicine solution that sets a new standard for comprehensive tailored PGx testing. Castle Bioscience’s unique bioinformatics platform integrates drug-gene, drug-drug metabolic interactions and lifestyle factors into a clinically actionable report.

PGx testing helps to determine a person’s metabolic phenotype – how their genes will impact their metabolism of drugs. Some people have genes that cause them to metabolize medicine very rapidly. Individuals with gene mutations associated with rapid metabolism may require higher doses of a medicine for it to have the same effect as someone with a lower metabolism. They may also experience fewer side effects.

Making matches on the molecular level

The one-size-fits-all approach to mental health treatment works for no one. IDgenetix is a comprehensive pharmacogenomics (PGx) test that provides personalized medication profiles, tailored to a patient’s unique DNA. The test accounts for more factors that can influence a patient’s response to medication than any other PGx test.

Rethink medication selection. Increase remission rates.

Trial and error no longer needs to be the standard of care for mental health treatment. IDgenetix is a comprehensive pharmacogenomic test proven to help improve medication response and remission rates.
In a randomized controlled trial, patients whose clinicians received their IDgenetix results had a better chance of responding to medication and achieving remission.

Please visit Castle Bioscience’s website for more information: https://castlebiosciences.com/tests/pharmacogenomic-pgx/idgenetix/overview